metaxalone
Generic: metaxalone
Labeler: phoenix rx llcDrug Facts
Product Profile
Brand Name
metaxalone
Generic Name
metaxalone
Labeler
phoenix rx llc
Dosage Form
TABLET
Routes
Active Ingredients
metaxalone 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
85509-2341
Product ID
85509-2341_41ae7309-4967-b721-e063-6294a90abf2c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203695
Listing Expiration
2026-12-31
Marketing Start
2017-06-19
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
855092341
Hyphenated Format
85509-2341
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
metaxalone (source: ndc)
Generic Name
metaxalone (source: ndc)
Application Number
ANDA203695 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (85509-2341-1)
- 120 TABLET in 1 BOTTLE (85509-2341-2)
- 30 TABLET in 1 BOTTLE (85509-2341-3)
- 60 TABLET in 1 BOTTLE (85509-2341-6)
- 90 TABLET in 1 BOTTLE (85509-2341-9)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "41ae7309-4967-b721-e063-6294a90abf2c", "openfda": {"nui": ["N0000175730", "N0000175737"], "unii": ["1NMA9J598Y"], "rxcui": ["351254"], "spl_set_id": ["3a7c8b4d-7add-cb31-e063-6294a90a37f8"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["PHOENIX RX LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (85509-2341-1)", "package_ndc": "85509-2341-1", "marketing_start_date": "20250731"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (85509-2341-2)", "package_ndc": "85509-2341-2", "marketing_start_date": "20250731"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (85509-2341-3)", "package_ndc": "85509-2341-3", "marketing_start_date": "20250731"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (85509-2341-6)", "package_ndc": "85509-2341-6", "marketing_start_date": "20250731"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (85509-2341-9)", "package_ndc": "85509-2341-9", "marketing_start_date": "20250731"}], "brand_name": "Metaxalone", "product_id": "85509-2341_41ae7309-4967-b721-e063-6294a90abf2c", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "85509-2341", "generic_name": "Metaxalone", "labeler_name": "PHOENIX RX LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Metaxalone", "active_ingredients": [{"name": "METAXALONE", "strength": "800 mg/1"}], "application_number": "ANDA203695", "marketing_category": "ANDA", "marketing_start_date": "20170619", "listing_expiration_date": "20261231"}